Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Revenue projections:

Revenue projections for GRANULES
Revenue projections for GRANULES

Granules India Limited's revenue projections indicate a decrease from the prior year, which may make investors hesitant. A revenue decline could harm the company's bottom line, prompting investors to be more careful, as lower earnings often signal potential issues with profitability and future performance.

Financial Ratios:

currentRatio 1.555000
forwardPE 17.424463
debtToEquity 39.153000
earningsGrowth 0.173000
revenueGrowth 0.018000
grossMargins 0.614940
operatingMargins 0.157720
trailingEps 20.690000
forwardEps 0.000000

GRANULES's current ratio of 1.555 means the company has enough liquidity to meet its short-term debt obligations. With sufficient cash reserves and current assets, GRANULES can comfortably cover its liabilities, reflecting a strong financial outlook.
GRANULES's Forward PE ratio is favorable, meaning the stock price aligns well with earnings and isn't overvalued. This allows room for growth, making it an attractive investment for those seeking potential upside while ensuring the stock is not overpriced.

Price projections:

Price projections for GRANULES
Price projections for GRANULES

GRANULES's present price, in relation to projections, does not offer clear risks or opportunities. This stable scenario suggests a period of consolidation, where investors might prefer to hold off on significant changes in strategy.

Recommendation changes over time:

Recommendations trend for GRANULES
Recommendations trend for GRANULES


Analysts have maintained a buy bias for Granules India Limited, which could prompt investors to consider the stock as a viable investment. With this positive outlook, Granules India Limited is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.